SFX by Ex Libris Inc.

Title:	Molecular pathogenesis of megalencephalic leukoencephalopathy with subcortical cysts: mutations in MLC1 cause folding defects
Source:	Human Molecular Genetics [0964-6906] Duarri, A yr:2008

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	van der Lei, Hannemieke D D. "Characteristics of early MRI in children and adolescents with vanishing white matter." Neuropediatrics 43.1 (2012): 22-26.
description	2.	Chayakulkeeree, M. "Role and mechanism of phosphatidylinositol-specific phospholipase C in survival and virulence of Cryptococcus neoformans." Molecular microbiology 69.4 (2008): 809-826.
description	3.	Hu, G. "Metabolic adaptation in Cryptococcus neoformans during early murine pulmonary infection." Molecular microbiology 69.6 (2008): 1456-1475.
description	4.	Bugiani, M. "Leukoencephalopathy With Vanishing White Matter: A Review." Journal of neuropathology and experimental neurology 69.10 (2010): 987-996.
description	5.	Gowda, V. "Case of Childhood Ataxia with Central Nervous System Hypomyelination with a Novel Mutation in EIF2B3 gene." Journal of pediatric neurosciences. 12.2: 196-198.
description	6.	Gungor, O. "A rare mutation in EIF2B4 gene in an epileptic child with vanishing white matter disease: a case report." Genetic counseling 26.1 (2015): 41-6.
description	7.	van der Lei, Hannemieke D W D. "Restricted Diffusion in Vanishing White Matter." Archives of neurology (2012): 723-727.
description	8.	Meoded, A. "Leukoencephalopathy with Vanishing White Matter: Serial MRI of the Brain and Spinal Cord including Diffusion Tensor Imaging." Neuropediatrics 42.2 (2011): 82-85.
description	9.	Del Poeta, M. "The cryptococcal enzyme inositol phosphosphingolipid-phospholipase C confers resistance to the antifungal effects of macrophages and promotes fungal dissemination to the central nervous system." Infection and immunity 74.10 (2006): 5977-88.
description	10.	Fabian, J. "High-performance liquid chromatographic assay with ultraviolet spectrometric detection for the evaluation of inhibitors of phosphatidylinositol-specific phospholipase C." Analytical biochemistry 375.2 (2008): 291-298.
description	11.	Da Silva-Lopez, Raquel E. "Purification and subcellular localization of a secreted 75 kDa Trypanosoma cruzi serine oligopeptidase." Acta Tropica 107.2 (2008): 159-167.
description	12.	Schell, M. "Comparative genomics and an insect model rapidly identify novel virulence genes of Burkholderia mallei." Journal of bacteriology 190.7 (2008): 2306-2313.
description	13.	van der Knaap, Marjo S S. "Vanishing white matter disease." Lancet. Neurology 5.5 (2006): 413-423.
description	14.	Pronk, J C C. "[From gene to disease; a defect in the regulation of protein production leading to vanishing white matter]." Nederlands tijdschrift voor geneeskunde 146.41 (2002): 1933-6.
description	15.	Van Haren, K. "The life and death of oligodendrocytes in vanishing white matter disease." Journal of neuropathology and experimental neurology 63.6 (2004): 618-30.
description	16.	Rodriguez, D. "Increased density of oligodendrocytes in childhood ataxia with diffuse central hypomyelination (CACH) syndrome: neuropathological and biochemical study of two cases." Acta neuropathologica 97.5 (1999): 469-80.
description	17.	Valk, J G. "Phenotypic variation in leukoencephalopathy with vanishing white matter." Neurology 51.2 (1998): 540-7.
description	18.	Liu, Authors R. "Severity of Vanishing White Matter disease does not correlate with deficits in eIF2B activity or the integrity of eIF2B complexes." Human mutation 32.9 (2011): 1036-1045.
description	19.	Rodrigues, Marcio L. "Extracellular vesicles produced by Cryptococcus neoformans contain protein components associated with virulence." Eukaryotic cell 7.1 (2007): 58-67.
description	20.	Schmidt, C. "Amyloid precursor protein and amyloid beta-peptide bind to ATP synthase and regulate its activity at the surface of neural cells." Molecular psychiatry 13.10 (2007): 953-69.